220.59
Amazon Com Inc stock is traded at $220.59, with a volume of 30.02M.
It is down -3.11% in the last 24 hours and down -4.20% over the past month.
Amazon is the leading online retailer and marketplace for third party sellers. Retail related revenue represents approximately 75% of total, followed by Amazon Web Services' cloud computing, storage, database, and other offerings (15%), advertising services (5% to 10%), and other the remainder. International segments constitute 25% to 30% of Amazon's non-AWS sales, led by Germany, the United Kingdom, and Japan.
See More
Previous Close:
$227.74
Open:
$226.21
24h Volume:
30.02M
Relative Volume:
0.72
Market Cap:
$2.36T
Revenue:
$670.04B
Net Income/Loss:
$70.62B
P/E Ratio:
33.66
EPS:
6.5528
Net Cash Flow:
$13.48B
1W Performance:
+0.52%
1M Performance:
-4.20%
6M Performance:
+21.76%
1Y Performance:
+18.22%
Amazon Com Inc Stock (AMZN) Company Profile
Name
Amazon Com Inc
Sector
Industry
Phone
(206) 266-1000
Address
410 TERRY AVENUE NORTH, SEATTLE, WA
Compare AMZN with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
AMZN
Amazon Com Inc
|
220.87 | 2.43T | 670.04B | 70.62B | 13.48B | 6.5528 |
![]()
BABA
Alibaba Group Holding Ltd Adr
|
162.65 | 402.76B | 138.70B | 20.31B | 20.83B | 8.573 |
![]()
PDD
Pdd Holdings Inc Adr
|
125.89 | 186.33B | 56.77B | 13.58B | 13.24B | 9.1713 |
![]()
MELI
Mercadolibre Inc
|
2,138.25 | 115.34B | 24.10B | 2.05B | 5.79B | 40.50 |
![]()
SE
Sea Ltd Adr
|
183.30 | 111.30B | 19.42B | 1.22B | 4.57B | 1.9734 |
Amazon Com Inc Stock (AMZN) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Oct-03-25 | Reiterated | Goldman | Buy |
Sep-30-25 | Initiated | Mizuho | Outperform |
Sep-24-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Sep-16-25 | Reiterated | Truist | Buy |
Aug-01-25 | Reiterated | Barclays | Overweight |
Aug-01-25 | Reiterated | BofA Securities | Buy |
Aug-01-25 | Reiterated | Cantor Fitzgerald | Overweight |
Aug-01-25 | Reiterated | Citigroup | Buy |
Aug-01-25 | Reiterated | DA Davidson | Buy |
Aug-01-25 | Reiterated | JP Morgan | Overweight |
Aug-01-25 | Reiterated | Monness Crespi & Hardt | Buy |
Aug-01-25 | Reiterated | Oppenheimer | Outperform |
Aug-01-25 | Reiterated | Piper Sandler | Overweight |
Aug-01-25 | Reiterated | Pivotal Research Group | Buy |
Aug-01-25 | Reiterated | Stifel | Buy |
Aug-01-25 | Reiterated | Susquehanna | Positive |
Aug-01-25 | Reiterated | Telsey Advisory Group | Outperform |
Jul-30-25 | Reiterated | Wedbush | Outperform |
Jul-29-25 | Reiterated | Stifel | Buy |
Jul-29-25 | Reiterated | Wells Fargo | Equal Weight |
Jul-28-25 | Reiterated | UBS | Buy |
Jul-23-25 | Reiterated | BofA Securities | Buy |
Jul-22-25 | Reiterated | Needham | Buy |
Jul-21-25 | Reiterated | Robert W. Baird | Outperform |
Jul-11-25 | Reiterated | JP Morgan | Overweight |
Jul-10-25 | Resumed | Citizens JMP | Mkt Outperform |
Jul-08-25 | Reiterated | Wells Fargo | Equal Weight |
Jul-02-25 | Reiterated | Truist | Buy |
Jun-27-25 | Upgrade | BNP Paribas Exane | Neutral → Outperform |
Jun-24-25 | Reiterated | MoffettNathanson | Buy |
Apr-23-25 | Reiterated | Telsey Advisory Group | Outperform |
Apr-22-25 | Reiterated | Jefferies | Buy |
Apr-21-25 | Downgrade | Raymond James | Strong Buy → Outperform |
Apr-16-25 | Reiterated | Cantor Fitzgerald | Overweight |
Apr-14-25 | Reiterated | Citigroup | Buy |
Apr-14-25 | Reiterated | Citizens JMP | Mkt Outperform |
Apr-14-25 | Reiterated | Deutsche Bank | Buy |
Apr-14-25 | Reiterated | Morgan Stanley | Overweight |
Jan-27-25 | Reiterated | Wedbush | Outperform |
Jan-06-25 | Reiterated | Wedbush | Outperform |
Jan-03-25 | Reiterated | Wolfe Research | Outperform |
Dec-16-24 | Reiterated | UBS | Buy |
Nov-14-24 | Reiterated | Needham | Buy |
Nov-01-24 | Reiterated | Monness Crespi & Hardt | Buy |
Nov-01-24 | Reiterated | Telsey Advisory Group | Outperform |
Oct-16-24 | Reiterated | Loop Capital | Buy |
Oct-11-24 | Initiated | Pivotal Research Group | Buy |
Oct-11-24 | Initiated | Scotiabank | Sector Outperform |
Oct-09-24 | Reiterated | Cantor Fitzgerald | Overweight |
Oct-07-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Sep-05-24 | Initiated | Cantor Fitzgerald | Overweight |
Aug-02-24 | Downgrade | Itau BBA | Outperform → Market Perform |
Aug-02-24 | Reiterated | Maxim Group | Buy |
Jul-30-24 | Reiterated | UBS | Buy |
Jul-17-24 | Reiterated | Needham | Buy |
Jul-16-24 | Reiterated | Goldman | Buy |
Jul-16-24 | Initiated | Wolfe Research | Outperform |
Jul-10-24 | Reiterated | TD Cowen | Buy |
May-01-24 | Reiterated | Maxim Group | Buy |
May-01-24 | Reiterated | Monness Crespi & Hardt | Buy |
May-01-24 | Reiterated | Telsey Advisory Group | Outperform |
Apr-17-24 | Initiated | Maxim Group | Buy |
Apr-17-24 | Reiterated | Truist | Buy |
Feb-02-24 | Reiterated | JMP Securities | Mkt Outperform |
Feb-02-24 | Reiterated | JP Morgan | Overweight |
Feb-02-24 | Reiterated | Mizuho | Buy |
Feb-02-24 | Reiterated | Monness Crespi & Hardt | Buy |
Feb-02-24 | Reiterated | Morgan Stanley | Overweight |
Feb-02-24 | Reiterated | Needham | Buy |
Feb-02-24 | Reiterated | Oppenheimer | Outperform |
Feb-02-24 | Reiterated | Piper Sandler | Overweight |
Feb-02-24 | Reiterated | ROTH MKM | Buy |
Feb-02-24 | Reiterated | Raymond James | Strong Buy |
Feb-02-24 | Reiterated | Robert W. Baird | Outperform |
Feb-02-24 | Reiterated | Seaport Research Partners | Buy |
Feb-02-24 | Reiterated | Stifel | Buy |
Feb-02-24 | Reiterated | Susquehanna | Positive |
Feb-02-24 | Reiterated | TD Cowen | Outperform |
Feb-02-24 | Reiterated | Telsey Advisory Group | Outperform |
Feb-02-24 | Reiterated | The Benchmark Company | Buy |
Feb-02-24 | Reiterated | Wedbush | Outperform |
Feb-02-24 | Reiterated | Wells Fargo | Overweight |
Feb-02-24 | Reiterated | Wolfe Research | Outperform |
Jan-24-24 | Reiterated | Telsey Advisory Group | Outperform |
Jan-17-24 | Reiterated | Wells Fargo | Overweight |
Jan-09-24 | Initiated | BMO Capital Markets | Outperform |
Jan-03-24 | Resumed | DA Davidson | Buy |
Dec-22-23 | Reiterated | Needham | Buy |
Dec-20-23 | Resumed | Raymond James | Strong Buy |
Dec-18-23 | Reiterated | ROTH MKM | Buy |
Dec-14-23 | Reiterated | Piper Sandler | Overweight |
Nov-02-23 | Initiated | HSBC Securities | Buy |
Oct-24-23 | Initiated | Seaport Research Partners | Buy |
Oct-17-23 | Initiated | Stifel | Buy |
Aug-24-23 | Reiterated | Piper Sandler | Overweight |
Aug-23-23 | Reiterated | Loop Capital | Buy |
Aug-22-23 | Resumed | Wedbush | Outperform |
Aug-11-23 | Reiterated | Redburn | Buy |
Aug-04-23 | Upgrade | Exane BNP Paribas | Underperform → Neutral |
Aug-04-23 | Reiterated | JP Morgan | Overweight |
Aug-04-23 | Reiterated | Mizuho | Buy |
Aug-04-23 | Reiterated | Morgan Stanley | Overweight |
Aug-04-23 | Reiterated | Needham | Buy |
Aug-04-23 | Reiterated | ROTH MKM | Buy |
Aug-04-23 | Reiterated | Robert W. Baird | Outperform |
Aug-04-23 | Upgrade | Rosenblatt | Neutral → Buy |
Aug-04-23 | Reiterated | Stifel | Buy |
Aug-04-23 | Reiterated | Susquehanna | Positive |
Aug-04-23 | Reiterated | TD Cowen | Outperform |
Aug-04-23 | Reiterated | Telsey Advisory Group | Outperform |
Aug-04-23 | Reiterated | The Benchmark Company | Buy |
Aug-04-23 | Reiterated | Truist | Buy |
Aug-04-23 | Reiterated | UBS | Buy |
Aug-04-23 | Reiterated | Wedbush | Outperform |
Apr-24-23 | Reiterated | MoffettNathanson | Outperform |
Apr-24-23 | Reiterated | UBS | Buy |
Apr-18-23 | Reiterated | Deutsche Bank | Buy |
Apr-06-23 | Reiterated | Oppenheimer | Outperform |
Jan-30-23 | Reiterated | Barclays | Overweight |
Jan-30-23 | Reiterated | Credit Suisse | Outperform |
Jan-25-23 | Reiterated | UBS | Buy |
Jan-24-23 | Reiterated | Telsey Advisory Group | Outperform |
Jan-18-23 | Reiterated | MKM Partners | Buy |
Jan-04-23 | Initiated | New Street | Buy |
Nov-15-22 | Initiated | MoffettNathanson | Outperform |
Oct-28-22 | Reiterated | Monness Crespi & Hardt | Buy |
Oct-28-22 | Reiterated | Morgan Stanley | Overweight |
Oct-28-22 | Reiterated | Needham | Buy |
Oct-28-22 | Reiterated | Oppenheimer | Outperform |
Oct-28-22 | Reiterated | RBC Capital Mkts | Outperform |
Oct-28-22 | Reiterated | Raymond James | Outperform |
Oct-28-22 | Reiterated | Robert W. Baird | Outperform |
Oct-28-22 | Reiterated | Telsey Advisory Group | Outperform |
Oct-28-22 | Reiterated | The Benchmark Company | Buy |
Oct-28-22 | Reiterated | Truist | Buy |
Oct-28-22 | Reiterated | Wedbush | Outperform |
Oct-28-22 | Reiterated | Wells Fargo | Overweight |
Oct-28-22 | Reiterated | Wolfe Research | Outperform |
Jun-29-22 | Initiated | Redburn | Buy |
Jun-01-22 | Resumed | JMP Securities | Mkt Outperform |
Apr-29-22 | Reiterated | Monness Crespi & Hardt | Buy |
Apr-20-22 | Resumed | Citigroup | Buy |
Apr-19-22 | Initiated | Rosenblatt | Neutral |
Mar-29-22 | Initiated | Exane BNP Paribas | Underperform |
Mar-11-22 | Initiated | Deutsche Bank | Buy |
Feb-04-22 | Reiterated | Barclays | Overweight |
Feb-04-22 | Reiterated | Canaccord Genuity | Buy |
Feb-04-22 | Reiterated | Credit Suisse | Outperform |
Feb-04-22 | Reiterated | Goldman | Buy |
Feb-04-22 | Reiterated | JP Morgan | Overweight |
Feb-04-22 | Reiterated | MKM Partners | Buy |
Feb-04-22 | Reiterated | Piper Sandler | Overweight |
Feb-04-22 | Reiterated | Raymond James | Outperform |
Feb-04-22 | Reiterated | UBS | Buy |
Feb-04-22 | Reiterated | Wolfe Research | Outperform |
Dec-13-21 | Reiterated | Cowen | Outperform |
Dec-02-21 | Resumed | UBS | Buy |
Nov-23-21 | Resumed | Guggenheim | Buy |
Oct-29-21 | Reiterated | Barclays | Overweight |
Oct-29-21 | Reiterated | Credit Suisse | Outperform |
Oct-29-21 | Reiterated | Evercore ISI | Outperform |
Oct-29-21 | Reiterated | Jefferies | Buy |
Oct-29-21 | Reiterated | Mizuho | Buy |
Oct-29-21 | Reiterated | Morgan Stanley | Overweight |
Oct-29-21 | Reiterated | Piper Sandler | Overweight |
Oct-29-21 | Reiterated | RBC Capital Mkts | Outperform |
Oct-29-21 | Reiterated | Raymond James | Outperform |
Oct-29-21 | Reiterated | Telsey Advisory Group | Outperform |
Oct-29-21 | Reiterated | The Benchmark Company | Buy |
Oct-29-21 | Reiterated | Truist | Buy |
Oct-29-21 | Reiterated | Wedbush | Outperform |
Oct-29-21 | Reiterated | Wolfe Research | Outperform |
Oct-22-21 | Reiterated | Credit Suisse | Outperform |
Oct-07-21 | Reiterated | Cowen | Outperform |
Oct-01-21 | Initiated | RBC Capital Mkts | Outperform |
Sep-27-21 | Reiterated | Morgan Stanley | Overweight |
Sep-14-21 | Reiterated | Evercore ISI | Outperform |
Sep-13-21 | Initiated | Goldman | Buy |
Jul-30-21 | Reiterated | BMO Capital Markets | Outperform |
Jul-30-21 | Reiterated | BofA Securities | Buy |
Jul-30-21 | Reiterated | Cowen | Outperform |
Jul-30-21 | Reiterated | Mizuho | Buy |
Jul-30-21 | Reiterated | Morgan Stanley | Overweight |
Jul-30-21 | Reiterated | Raymond James | Outperform |
Jul-30-21 | Reiterated | Susquehanna | Positive |
Jul-30-21 | Reiterated | The Benchmark Company | Buy |
Jul-30-21 | Reiterated | Truist | Buy |
Apr-16-21 | Reiterated | Credit Suisse | Outperform |
Apr-06-21 | Resumed | Evercore ISI | Outperform |
Apr-01-21 | Initiated | Wolfe Research | Outperform |
Feb-03-21 | Reiterated | Barclays | Overweight |
Feb-03-21 | Reiterated | Canaccord Genuity | Buy |
Feb-03-21 | Reiterated | Cowen | Outperform |
Feb-03-21 | Reiterated | Credit Suisse | Outperform |
Feb-03-21 | Reiterated | Deutsche Bank | Buy |
Feb-03-21 | Reiterated | Goldman | Buy |
Feb-03-21 | Reiterated | Guggenheim | Buy |
Feb-03-21 | Reiterated | JP Morgan | Overweight |
Feb-03-21 | Reiterated | Jefferies | Buy |
Feb-03-21 | Reiterated | MKM Partners | Buy |
Feb-03-21 | Reiterated | Monness Crespi & Hardt | Buy |
Feb-03-21 | Reiterated | Oppenheimer | Outperform |
Feb-03-21 | Reiterated | Pivotal Research Group | Buy |
Feb-03-21 | Reiterated | Raymond James | Outperform |
Feb-03-21 | Reiterated | Stifel | Buy |
Feb-03-21 | Reiterated | Susquehanna | Positive |
Feb-03-21 | Reiterated | UBS | Buy |
Feb-03-21 | Reiterated | Wedbush | Outperform |
Jan-22-21 | Reiterated | Credit Suisse | Outperform |
Nov-04-20 | Upgrade | China Renaissance | Hold → Buy |
Oct-30-20 | Reiterated | Monness Crespi & Hardt | Buy |
Oct-07-20 | Reiterated | The Benchmark Company | Buy |
Oct-01-20 | Reiterated | Pivotal Research Group | Buy |
Sep-25-20 | Resumed | Piper Sandler | Overweight |
Sep-22-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
Jul-31-20 | Reiterated | Canaccord Genuity | Buy |
Jul-31-20 | Reiterated | Credit Suisse | Outperform |
Jul-31-20 | Reiterated | Deutsche Bank | Buy |
Jul-31-20 | Reiterated | JMP Securities | Mkt Outperform |
Jul-31-20 | Reiterated | KeyBanc Capital Markets | Overweight |
Jul-31-20 | Reiterated | Mizuho | Buy |
Jul-31-20 | Reiterated | Monness Crespi & Hardt | Buy |
Jul-31-20 | Reiterated | Morgan Stanley | Overweight |
Jul-31-20 | Reiterated | Needham | Buy |
Jul-31-20 | Reiterated | RBC Capital Mkts | Outperform |
Jul-31-20 | Reiterated | SunTrust | Buy |
Jul-31-20 | Reiterated | Telsey Advisory Group | Outperform |
Jul-31-20 | Reiterated | UBS | Buy |
Jul-31-20 | Reiterated | Wedbush | Outperform |
View All
Amazon Com Inc Stock (AMZN) Latest News
Amazon set to open delivery facility in northeast Missouri - KTVO
Amazon Prime Day ends tonight: Grab these top best sellers still in stock! - Global News
Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally - Investing.com
Amazon (NASDAQ: AMZN) Stock Price Prediction in 2030: Bull, Bear, & Baseline Forecasts (Oct 10) - 24/7 Wall St.
Better Buy: Amazon vs. Target - The Globe and Mail
Why this money manager is buying Amazon and selling SAP - The Globe and Mail
Neil Young Says His Music Will Be Pulled from Amazon: 'Go to the Local Store' - People.com
James Bond Disarmed: Amazon Removes Guns from ‘007 Series’ Posters - 매일경제
Rishi Sunak Joins Microsoft, Amazon-Backed Anthropic As Senior Adviser: 'Proceeds From These Roles Will Be Donated In Full' - Benzinga
Why Amazon’s Prime Day May Be the Catalyst for a Year-End Rally - MarketBeat
Amazon, YouTube Leading New Media Convergence - MarketScreener
Amazon’s (AMZN) Expanding AI Tools and Prime Growth Keep Momentum Strong - Yahoo Finance
Amazon Stock Surges After Strong Prime Big Deal Days Performance - TECHi
Days After an Array of New Amazon Devices Debut, A Devices VP is Leaving the Company - Strata-gee.com
AWS Quick Suite: New AI Chatbot and Agent Suite for BusinessNews and Statistics - IndexBox
Amazon coming to Monett - Lawrence County Record
Amazon Reboots AI Agent for Workers, Taking on ChatGPT, Copilot - Bloomberg.com
Boeing, Amazon.com Inc. share losses lead Dow's 140-point fall - MSN
Amazon: Don't Discount The Seemingly Forgotten #1 Hyperscaler (NASDAQ:AMZN) - Seeking Alpha
Exclusive: Amazon just opened the warehouse of the future in rural Indiana - Fast Company
Precision Trading with Amazon.com Inc. (AMZN) Risk Zones - news.stocktradersdaily.com
What to know about wild week of sales at Walmart, Target, and Amazon - DC News Now
Judge OKs Amazon's Evidence Clawback In Antitrust Suits - Law360
Amazon’s SWOT analysis: stock poised for growth amid challenges in diverse markets - Investing.com
Jeff Bezos | Biography, Wedding, Amazon.com, & Facts - Britannica
I Polled All The Parents I Know – Here Are The Buys That You Should Not Miss On Prime Day - HuffPost
Market Voices: Verizon's Starry, AST deals; Amazon's drug kiosks - Seeking Alpha
Amazon's Fintech Play With UPI Circle: Can the Technology Deliver? - The Globe and Mail
Amazon Pharmacy to launch electronic kiosks for prescriptions at One Medical locations - Reuters
Amazon and Bad Bunny Bet Big on ‘Made in PR’ - Yahoo Finance
Amazon Stock (NASDAQ: AMZN) Price Prediction and Forecast 2025-2030 for October 8 - 24/7 Wall St.
Amazon (AMZN) Stock: Edges Higher Amid Major $1.2B Infrastructure Push in Belgium - CoinCentral
Amazon (AMZN) Stock: Why This Top Analyst Sees 21% Upside Ahead - parameter.io
Amazon Returns Are Showing Up at a Random Burlington Home - Seven Days Vermont
Amazon To Invest $1.16 Billion In Belgium, Unveils Pharmacy Kiosks Rollout - Benzinga
Think You Know Amazon? Here's 1 Little-Known Fact You Can't Overlook. - Yahoo Finance
Amazon (AMZN) Unveils Pharmacy Kiosks for Quick Prescription Acc - GuruFocus
Amazon | E-commerce, Amazon Web Services, History, & Facts - Britannica
Amazon Pharmacy Launches In-Office Kiosks to Help Patients Get Medications Immediately After Appointments - Business Wire
“OpenAI Monday” Boosts Amazon (AMZN) Sentiment: Baird Stays Bullish on AWS Momentum - Yahoo Finance
Amazon agrees to historic $2.5B settlement over deceptive Prime practices - Class Action Lawsuits
Amazon to invest $1.16 billion in Belgium by 2027, L'Echo reports - MarketScreener
Anthropic's New Claude Detects Evaluations: 'I Think You're Testing Me' — Raising Fresh Questions About AI Self-Awareness - Benzinga
Goldman Sachs Lifts PT on Amazon.com (AMZN) Stock - MSN
Amazon buys $97 million mega warehouse to expand US distribution network - USA Today
Amazon Com Inc Stock (AMZN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):